Application 203158

Type
ANDA
Sponsor
NORTEC DEV ASSOC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MORPHINE SULFATEMORPHINE SULFATECAPSULE, EXTENDED RELEASE;ORAL20MGNoNo
002MORPHINE SULFATEMORPHINE SULFATECAPSULE, EXTENDED RELEASE;ORAL30MGNoNo
003MORPHINE SULFATEMORPHINE SULFATECAPSULE, EXTENDED RELEASE;ORAL50MGNoNo
004MORPHINE SULFATEMORPHINE SULFATECAPSULE, EXTENDED RELEASE;ORAL60MGNoNo
005MORPHINE SULFATEMORPHINE SULFATECAPSULE, EXTENDED RELEASE;ORAL80MGNoNo
006MORPHINE SULFATEMORPHINE SULFATECAPSULE, EXTENDED RELEASE;ORAL100MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
42689-005Morphine Sulfatemorphine sulfateNortec Development Associates, Inc.ANDACurrent
42689-006Morphine Sulfatemorphine sulfateNortec Development Associates, Inc.ANDACurrent
42689-007Morphine Sulfatemorphine sulfateNortec Development Associates, Inc.ANDACurrent
42689-008Morphine Sulfatemorphine sulfateNortec Development Associates, Inc.ANDACurrent
42689-009Morphine Sulfatemorphine sulfateNortec Development Associates, Inc.ANDACurrent
42689-010Morphine Sulfatemorphine sulfateNortec Development Associates, Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
76475ORIG 2023-11-07